Skip to main content

Table 1 Effect size by outcome and funding source

From: Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis

Outcome Number of studies Number of animals Heterogeneity (I2) Effect size* (95% CI)
Atherosclerosis 49 3498 73 −1.25 (−1.56, −0.94)
Funding Source     
Industry 15   18 −0.73 (−1.00, −0.47)
Non-industry 23   84 −1.99 (−2.68, −1.31)
No Statement 11   0 −0.93 (−1.24, −0.61)
Bone 45 1986 89 0.42 (0.00, 0.83)
Funding Source     
Industry 6   60 0.13 (−0.48, 0.73)
Non-industry 28   91 0.48 (−0.10, 1.06)
No Statement 11   80 0.39 (−0.36, 1.14)
  1. *Standardized Mean Difference As Estimated in DerSimonian Laird Random-Effects Models.